Recording | Samantha Farris, PhD Presentation: Targeting Fear and Avoidance of Exercise in Cardiac Rehabilitation

On February 17, 2021, SOBC and the Columbia Roybal Center for Fearless Behavior Change co-hosted a Grand Rounds Webinar with Dr. Samantha Farris who presented on Targeting Fear and Avoidance of Exercise in Cardiac Patients.

 

Presentation Recording: Link here

 

Talk Description: Dr. Farris discussed her translational research on exercise fear-avoidance and the application of this work to cardiac rehabilitation. She defines the construct of ‘interoceptive sensitivity’ and describes its multi-method measurement, and then introduces an exposure-based behavioral intervention to target interoceptive sensitivity and improve physical activity outcomes in cardiac rehabilitation.

read more »

 

February 17, 2021 | Samantha Farris, PhD Presentation: Targeting Fear and Avoidance of Exercise in Cardiac Rehabilitation

Co-hosted with Columbia Roybal Center for Fearless Behavior Change on February 17th at 12pm EST, Dr. Samantha Farris will present on Targeting Fear and Avoidance of Exercise in Cardiac Patients.

To register: click here

 

Dr. Samantha Farris is an Assistant Professor in the Department of Psychology and is the Director of The Rutgers Emotion, Health and Behavior (REHAB) Laboratory. Dr. Farris received her Ph.D. in Clinical Psychology at The University of Houston, and completed her psychology internship at the Alpert Medical School at Brown University. She completed fellowships in cancer prevention at the University of Texas MD Anderson Cancer Center and in cardiovascular behavioral medicine at The Miriam Hospital/Alpert Medical School at Brown University. Dr. Farris has published over 100 peer-reviewed publications and has received continuous funding for her research from the National Institutes of Health. Dr. Farris’ research focuses on understanding how and why stress and anxiety (i.e., worry, fear, panic) commonly co-occur with and contribute to problematic health behaviors and chronic disease. She utilizes an experimental medicine approach to (a) identify cognitive-affective mechanisms that contribute to health behaviors and physical disease, (b) isolate how these mechanisms influence health behaviors “in real time” through use of laboratory methodologies, and in turn (c) develop tailored interventions that target these mechanisms to promote health behavior change and prevent the onset or progression of chronic disease. Dr. Farris is also a licensed clinical psychologist in the state of New Jersey, New York, and Rhode Island, and specializes in cognitive-behavioral therapy for the treatment of anxiety and related disorders.

 

 

 

January 6, 2021 | SOBC Webinar – Roles for Behavioral Science in COVID-19 Vaccination Efforts

Please join the SOBC Research Network and expert panelists as we host a webinar focused on the behavioral and social science challenges and solutions to the COVID-19 vaccine uptake/adoption, particularly in underserved populations.

 

The “Big Questions” we hope to address are: What can our understanding of the mechanisms of behavior change contribute to help solve the challenge of broad vaccine uptake/adoption, including in underserved populations? What does existing scientific evidence suggest concerning communication about the science of COVID-19 vaccines and/or the availability/prioritization of vaccines in different communities? What role can/should behavioral science play in preparing the nation for a vaccine?

 

SOBC COVID-19 Webinar Information Sheet

To register for this webinar on January 6, 2021 at 1:30pm EST click here.

 

Recording | Lisa Marsch, PhD Presents: Digital Therapeutics for Health Behavior Change: The State of the Science

Presentation recording here.

 

Lisa A. Marsch, PhD is the Director of the Center for Technology and Behavioral Health (CTBH), the Director of the Northeast Node of the National Drug Abuse Treatment Clinical Trials Network, and the Andrew G. Wallace Professor within the Geisel School of Medicine at Dartmouth College. CTBH is an interdisciplinary “Center of Excellence”, supported by the U.S. National Institute on Drug Abuse, that uses science to inform the development, evaluation, and sustainable implementation of digital therapeutics (that leverage web, mobile, sensing and/or social media approaches) in the treatment of persons with substance use disorders and other behavioral health challenges. These tools are designed to deliver engaging and effective health monitoring and health behavior interventions to collectively lead to transformations in the delivery of science-based behavioral health treatment.

 

Recording | Kenneth Freedland, PhD Presents: Pilot Trials of Health-Related Behavioral Interventions: Problems, Solutions, and Recommendations

Presentation recording here.

 

Dr. Kenneth Freedland is a Professor of Psychiatry and Psychology at Washington University School of Medicine in St. Louis, the Editor-in-Chief of Health Psychology, and the Program Director of the annual NIH/OBSSR Summer Institute on Randomized Behavioral Clinical Trials. His methodological interests include feasibility and pilot studies and the selection and design of comparators for randomized controlled trials of health-related behavioral interventions. He chaired the NIH/OBSSR Expert Panel on Comparator Group Selection in Behavioral and Social Science Clinical Trials and has published several papers and chapters on comparators and on pilot studies.

read more »

 

April 27, 2020 | Dr. Kevin Volpp Presenting on Behavioral Economics and Health

Dr. Kevin Volpp is the Founders Presidential Distinguished Professor at the School of Medicine and the Wharton School at the University of Pennsylvania and the Director of the Penn Roybal Center for Health Incentives and Behavioral Economics (CHIBE), 1 of 2 original NIH-funded Centers in Behavioral Economics and health. He is also the Division Chief of Health Policy for the Department of Medical Ethics and Health Policy and a special advisor to the CEO of Penn Medicine and the Dean/EVP. He is known nationally and internationally for developing the application of behavioral economics to health and for designing and testing initiatives to improve health that have been implemented in tens of millions of Americans. He has garnered numerous awards for his research including election into the National Academy of Medicine, the British Medical Journal Group Award for Translating Research into Practice, and Article of the Year and Career Achievement Awards from multiple societies, including from NIH for work in social and behavioral sciences and the John Eisenberg Award from the Society of General Internal Medicine. He served on the Editorial Board of the Annals of Internal Medicine and as a Contributing Writer to JAMA and is now on the Editorial Board of the NEJM Catalyst.

 

Access the lecture via the following information:
Meeting URL: https://meetings.webex.com/collabs/#/meetings/joinbynumber

Meeting Number: 191 616 728

 

February 18, 2020 | Dr. Marie “Tonette” Krousel-Wood Presentation on Implicit Attitudes and Medication Adherence: Tactic or Target for Innovative Interventions to Improve Adherence?

M.A. “Tonette” Krousel-Wood MD, MSPH, FACPM, FAHA is Professor of Medicine in the Tulane School of Medicine, Professor of Epidemiology in the Tulane School of Public Health and Tropical Medicine, and serves in several leadership roles at Tulane including the Associate Provost for the Health Sciences at Tulane University. She is actively engaged as the principal and co-investigator in NIH-funded clinical research and clinical trials focused on overall and sex differences in adherence to prescribed therapies for chronic diseases, management of hypertension, and health outcomes and implementations research focused on women and men with chronic cardiometabolic diseases in rural and underserved areas.

Access the lecture via the following information:
Meeting URL: https://meetings.webex.com/collabs/#/meetings/joinbynumber

Meeting Number: 190 637 608

read more »

 

December 16, 2019 | Drs. Carolyn Thorpe, Corrine Voils, and Ian Kronish Presenting on Measuring the Multiple Dimensions of Medication Nonadherence in Behavior Change Research

Have you ever wondered how best to measure medication nonadherence? Medication nonadherence is one of the health behaviors with the strongest influence on chronic disease outcomes. Yet, there is no single gold-standard approach for its measurement. This webinar will review the findings from a recent Delphi survey of medication adherence experts focused on eliciting best practices for assessing medication adherence in behavior change research.

Join us for a video lecture and discussion on December 16th, from 2-3pm EST.

Access the lecture via the following information:
Meeting URL: https://meetings.webex.com/collabs/#/meetings/joinbynumber

Meeting Number: 195 965 196